11 / 27
Page 39
Notes:
allied
academies
August 27-28, 2018 | London, UK
International Conference on
Healthcare and Health Management
Cardiology and Cardiac Surgery
Joint Event
&
Journal of Public Health Policy and Planning | Volume: 2
Off label prescribing practice in primary care physicians: A qualitative insight
Wajiha Iffat
1
, Sadia Shakeel
1
, Shagufta Nesar
2
, Hina Rehman
3
and
Muhammad Faisal Khan
1
1
Dow University of Health Sciences, Pakistan
2
Hamdard University, Pakistan
3
Jinnah University for Women, Pakistan
Context:
Despite the pharmaceutical products prescribed
for Food and Drug Administration–approved indications, off-
label uses may have deficiency of rigorous scientific scrutiny.
Regardless of concerns about patient care and health care
expenditure, little is knownabout the frequencyof off-label drug
use or the degree of scientific evidence supporting this practice.
Objectives:
The current study was conducted to observe the
opinion and of label prescribing practices of physicians in
Karachi, Pakistan .
Methods:
A cross sectional study was conducted during Feb-
July, 2018 in different health care setups. Health care workers
were assessed for prescribing practice of off label prescribing
in children by requesting them to fill and submit the survey
form. Multivariate analyses were used to identify drug-
specific characteristics predictive of increased off-label use.
Results:
The current study revealed that physicians
often used the practice of off label prescribing in
children. Majority of physicians considered that off label
prescribing is safe if used with strong scientific research.
Conclusions:
Off-label medication use is common in patient
care, and most occurs without scientific support. Efforts should
be made to scrutinize underevaluated off-label prescribing that
compromises patient safety or represents wasteful medication
use.
Speaker Biography
Wajiha Iffat is presently working as assistant professor in Faculty of pharmacy and
pharmaceutical sciences, Dow college of pharmacy, DUHS. She did her graduation
(B.Pharm) and post-graduation degree in pharmacy from University of Karachi. She
also holds D.H.M.S degree. She has obtained M.B.A. (marketing) from K.U.B.S, Karachi
University in 2010. She has recently obtained her Ph.D. degree in Pharmaceutics,
under the supervision of Prof. Harris Shoaib from department of Pharmaceutics,
Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi. She started
her professional career by working as production control inspector in Abbott
Laboratories (Pak) Ltd. She has also worked as trainer in project “a well-managed GP
clinic program” that was launched by IOBM in collaboration with Snofi Aventis. She
started her academic career in 2006 as lecturer. She joined Dow college of Pharmacy in
2008. Apart from academic activities, she was actively engaged as quality management
system coordinator where her main task was to improve the quality of education
system. She has also served as lead auditor and auditor in DUHS. She has also served as
focal person in execution of various co-curricular and extra-curricular activities. She has
around 50 publications to her credit. Her main research interest includes formulation
development and optimization, method development and validation, marketing and
management, pharmaco-economics and pharmacy practice. She has attended and
presented in seminars and symposiums organized by various academics institution.
e:
wajiha.iffat@duhs.edu.pk